Literature DB >> 16801529

In situ localization of P-glycoprotein (ABCB1) in human and rat brain.

Reina Bendayan1, Patrick T Ronaldson, Diane Gingras, Moise Bendayan.   

Abstract

Transport of several xenobiotics including pharmacological agents into or out of the central nervous system (CNS) involves the expression of ATP-dependent, membrane-bound efflux transport proteins such as P-glycoprotein (P-gp) at the blood-brain barrier (BBB). Previous studies have documented gene and protein expression of P-gp in brain microvessel endothelial cells. However, the exact localization of P-gp, particularly at the abluminal side of the BBB, remains controversial. In the present study we examined the cellular/subcellular distribution of P-gp in situ in rat and human brain tissues using immunogold cytochemistry at the electron microscope level. P-gp localizes to both the luminal and abluminal membranes of capillary endothelial cells as well as to adjacent pericytes and astrocytes. Subcellularly, P-gp is distributed along the nuclear envelope, in caveolae, cytoplasmic vesicles, Golgi complex, and rough endoplasmic reticulum (RER). These results provide evidence for the expression of P-gp in human and rodent brain capillary along their plasma membranes as well as at sites of protein synthesis, glycosylation, and membrane trafficking. In addition, its presence at the luminal and abluminal poles of the BBB, including pericytes and astrocyte plasma membranes, suggests that this glycoprotein may regulate drug transport processes in the entire CNS BBB at both the cellular and subcellular level.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16801529      PMCID: PMC3957801          DOI: 10.1369/jhc.5A6870.2006

Source DB:  PubMed          Journal:  J Histochem Cytochem        ISSN: 0022-1554            Impact factor:   2.479


  37 in total

Review 1.  Functional expression and localization of P-glycoprotein at the blood brain barrier.

Authors:  Reina Bendayan; Gloria Lee; Moise Bendayan
Journal:  Microsc Res Tech       Date:  2002-06-01       Impact factor: 2.769

2.  Interaction of combinations of drugs, chemosensitizers, and peptides with the P-glycoprotein multidrug transporter.

Authors:  G DiDiodato; F J Sharom
Journal:  Biochem Pharmacol       Date:  1997-06-15       Impact factor: 5.858

3.  Expression of P-glycoprotein in human cerebral cortex microvessels.

Authors:  Daniela Virgintino; David Robertson; Mariella Errede; Vincenzo Benagiano; Francesco Girolamo; Eugenio Maiorano; Luisa Roncali; Mirella Bertossi
Journal:  J Histochem Cytochem       Date:  2002-12       Impact factor: 2.479

Review 4.  Subcellular detection and localization of the drug transporter P-glycoprotein in cultured tumor cells.

Authors:  A Molinari; A Calcabrini; S Meschini; A Stringaro; P Crateri; L Toccacieli; M Marra; M Colone; M Cianfriglia; G Arancia
Journal:  Curr Protein Pept Sci       Date:  2002-12       Impact factor: 3.272

Review 5.  Colloidal gold post-embedding immunocytochemistry.

Authors:  M Bendayan
Journal:  Prog Histochem Cytochem       Date:  1995

6.  Contribution of glial cells and pericytes to the mRNA profiles of P-glycoprotein and multidrug resistance-associated proteins in an in vitro model of the blood-brain barrier.

Authors:  Vincent Berezowski; Christophe Landry; Marie-Pierre Dehouck; Roméo Cecchelli; Laurence Fenart
Journal:  Brain Res       Date:  2004-08-20       Impact factor: 3.252

7.  P-glycoprotein and caveolin-1alpha in endothelium and astrocytes of primate brain.

Authors:  Felix Schlachetzki; William M Pardridge
Journal:  Neuroreport       Date:  2003-11-14       Impact factor: 1.837

8.  Glial cells express multiple ATP binding cassette proteins which are involved in ATP release.

Authors:  Patrizia Ballerini; Patrizia Di Iorio; Renata Ciccarelli; Eleonora Nargi; Iolanda D'Alimonte; Ugo Traversa; Michel P Rathbone; Francesco Caciagli
Journal:  Neuroreport       Date:  2002-10-07       Impact factor: 1.837

9.  P-glycoprotein in blood-brain barrier endothelial cells: interaction and oligomerization with caveolins.

Authors:  Julie Jodoin; Michel Demeule; Laurence Fenart; Roméo Cecchelli; Sarah Farmer; Kenneth J Linton; Christopher F Higgins; Richard Béliveau
Journal:  J Neurochem       Date:  2003-11       Impact factor: 5.372

10.  The effects of protease inhibitors and nonnucleoside reverse transcriptase inhibitors on p-glycoprotein expression in peripheral blood mononuclear cells in vitro.

Authors:  Becky Chandler; Lisa Almond; Jennifer Ford; Andrew Owen; Patrick Hoggard; Saye Khoo; David Back
Journal:  J Acquir Immune Defic Syndr       Date:  2003-08-15       Impact factor: 3.731

View more
  80 in total

Review 1.  Blood-Brain Barrier Driven Pharmacoresistance in Amyotrophic Lateral Sclerosis and Challenges for Effective Drug Therapies.

Authors:  Loqman A Mohamed; Shashirekha Markandaiah; Silvia Bonanno; Piera Pasinelli; Davide Trotti
Journal:  AAPS J       Date:  2017-08-04       Impact factor: 4.009

2.  The expression of LDL receptor in vessels with blood-brain barrier impairment in a stroke-prone hypertensive model.

Authors:  Masaki Ueno; Bin Wu; Toshitaka Nakagawa; Yukiko Nagai; Masayuki Onodera; Cheng-Long Huang; Takashi Kusaka; Kenji Kanenishi; Haruhiko Sakamoto
Journal:  Histochem Cell Biol       Date:  2010-05-11       Impact factor: 4.304

Review 3.  Targeting blood-brain barrier changes during inflammatory pain: an opportunity for optimizing CNS drug delivery.

Authors:  Patrick T Ronaldson; Thomas P Davis
Journal:  Ther Deliv       Date:  2011-08

4.  Brain pericytes: emerging concepts and functional roles in brain homeostasis.

Authors:  Masahiro Kamouchi; Tetsuro Ago; Takanari Kitazono
Journal:  Cell Mol Neurobiol       Date:  2011-03       Impact factor: 5.046

Review 5.  Apicobasal polarity of brain endothelial cells.

Authors:  Thomas Worzfeld; Markus Schwaninger
Journal:  J Cereb Blood Flow Metab       Date:  2015-10-06       Impact factor: 6.200

6.  Identification of P-glycoprotein co-fractionating proteins and specific binding partners in rat brain microvessels.

Authors:  Margaret E Tome; Charles P Schaefer; Leigh M Jacobs; Yifeng Zhang; Joseph M Herndon; Fabian O Matty; Thomas P Davis
Journal:  J Neurochem       Date:  2015-04-21       Impact factor: 5.372

7.  The predictive value of ABCB1, ABCG2, CYP3A4/5 and CYP2D6 polymorphisms for risperidone and aripiprazole plasma concentrations and the occurrence of adverse drug reactions.

Authors:  C Rafaniello; M Sessa; F F Bernardi; M Pozzi; S Cheli; D Cattaneo; S Baldelli; M Molteni; R Bernardini; F Rossi; E Clementi; C Bravaccio; S Radice; A Capuano
Journal:  Pharmacogenomics J       Date:  2017-07-18       Impact factor: 3.550

Review 8.  Blood-brain barrier integrity and glial support: mechanisms that can be targeted for novel therapeutic approaches in stroke.

Authors:  Patrick T Ronaldson; Thomas P Davis
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

9.  Distribution of suramin, an antitrypanosomal drug, across the blood-brain and blood-cerebrospinal fluid interfaces in wild-type and P-glycoprotein transporter-deficient mice.

Authors:  Lisa Sanderson; Adil Khan; Sarah Thomas
Journal:  Antimicrob Agents Chemother       Date:  2007-06-18       Impact factor: 5.191

Review 10.  A role for pericytes in chronic pain?

Authors:  Alexandra M Durrant; Matthew N Swift; Nicholas Beazley-Long
Journal:  Curr Opin Support Palliat Care       Date:  2018-06       Impact factor: 2.302

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.